MiNA Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- MiNA Therapeutics's estimated annual revenue is currently $7M per year.
- MiNA Therapeutics's estimated revenue per employee is $155,000
Employee Data
- MiNA Therapeutics has 45 Employees.
- MiNA Therapeutics grew their employee count by -6% last year.
MiNA Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Group Chief Financial Officer | Reveal Email/Phone |
3 | Director, Genetic Medicine | Reveal Email/Phone |
4 | Office Manager | Reveal Email/Phone |
5 | Senior Principal Scientist | Reveal Email/Phone |
6 | Research Scientist | Reveal Email/Phone |
7 | Principal Patent Agent | Reveal Email/Phone |
8 | Senior Research Scientist | Reveal Email/Phone |
9 | Research Scientist | Reveal Email/Phone |
10 | Principal Scientist Bioinformatics | Reveal Email/Phone |
MiNA Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is MiNA Therapeutics?
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients' cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.
keywords:N/A
N/A
Total Funding
45
Number of Employees
$7M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MiNA Therapeutics News
2022-04-06 - MiNA Therapeutics Presents Proof of Mechanism Data on ...
MTL?STING is the second drug candidate to be advanced from MiNA's internal pipeline of RNAa therapeutics. MiNA's first drug candidate, MTL-CEBPA...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.1M | 45 | -6% | N/A |
#2 | $7.9M | 45 | 5% | N/A |
#3 | $4.7M | 45 | 0% | N/A |
#4 | $5.2M | 45 | -10% | N/A |
#5 | $8.4M | 45 | 50% | N/A |